肺腺癌IASLC/ATS/ERS国际多学科分类以及临床实践中应注意的问题  

The International Multidisciplinary Classification of Lung Adenocarcinoma from IASLC/ATS/ERS and Problems in Clinical Practice

作　　者：闫利娟 易祥华[2,3] 

机构地区：[1]洛阳市第二中医院病理科,洛阳471003 [2]同济大学附属同济医院 [3]上海市同济医院病理科,上海200065

出　　处：《中国肺癌杂志》2013年第7期333-338,共6页Chinese Journal of Lung Cancer

基　　金：上海市科学技术委员会科研基金项目(No.034119868);上海市科学技术委员会医学重点科研基金项目(No.09411951600)资助~~

摘　　要：2011年由国际肺癌研究协会(International Association for the Study of Lung Cancer,IASLC)、美国胸科学会(American Thoracic Society,ATS)和欧洲呼吸学会(European Respiratory Society,ERS)发表的肺腺癌国际多学科分类共识意见,首次提出了分别适用于手术切除标本、小活检及细胞学的分类方法,不再使用细支气管肺泡癌的名称,新增原位腺癌和微浸润性腺癌的命名,对浸润性腺癌提倡全面而详细的组织学诊断模式等。随着临床应用的深入,病理和临床医师对新分类的理解和应用在某些方面尚存在一定的困惑。本文对这一肺腺癌的国际多学科分类新标准进行解读并就临床实践中所应该注意的问题进行分析和讨论。The international multidisciplinary classification of lung adenocarcinoma sponsored by International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society in 2011, addresses the classification which is appropriate for resection specimens, small biopsies and cytology, respectively for the first time. For resection specimens, new concepts are introduced such as adenocarcinoma in situ （AIS） and minimally invasive adenocarcinoma （MIA）; Invasive adenocarcinomas are recommended to be classified by comprehensive histologic pattern. During the clinical practice, pathologists and clinicians have some confusions in understanding and application of to the new guideline to some extent. This paper will interpret this new guideline, discuss and analyze the issues that need to be noticed in clinical application.

关 键 词：肺肿瘤 分类 病理学 肿瘤学 

分 类 号：R734.2[医药卫生—肿瘤]